Literature DB >> 17823985

Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.

Takashi Kagari1, Daisuke Tanaka, Hiromi Doi, Yoichiro Iwakura, Takaichi Shimozato.   

Abstract

Arthritis can be induced in mice by the injection of anti-type II collagen (anti-CII) Ab and LPS. To elucidate the role of IL-1 receptor antagonist (IL-1ra) in Ab-induced arthritis, WT and IL-1ra(-/-) mice were administered anti-CII Ab and LPS. These IL-1ra(-/-) mice developed severe arthritis even at low doses of anti-CII Ab and LPS, while WT mice did not. The cells that invaded the arthritic joints were mainly Gr-1(+) neutrophils, and the number of the cells in the joints remained high over 4 weeks in the IL-1ra(-/-) mice. KC, a ligand for CXCR2, is found in higher levels in the arthritic paws of IL-1ra(-/-) mice compared with the WT, and most of the cells that infiltrated into the joints of the IL-1ra(-/-) mice were CXCR2-expressing neutrophils. Administration of anti-CXCR2 Ab completely inhibited arthritis development. The anti-CXCR2 Ab decreased the number of neutrophils in the blood and also inhibited the migration of neutrophils to KC. These results suggested that the high susceptibility of IL-1ra(-/-) mice to anti-CII Ab-induced arthritis was due to the higher expression of chemotactic factors like KC and the sustained infiltration of CXCR2-expressing neutrophils into the joints.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823985     DOI: 10.1002/eji.200737313

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis.

Authors:  Kira Minkis; Ivona Aksentijevich; Raphaela Goldbach-Mansky; Cynthia Magro; Rachelle Scott; Jessica G Davis; Niti Sardana; Ronit Herzog
Journal:  Arch Dermatol       Date:  2012-06

2.  Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization.

Authors:  Sarah R Pickens; Nathan D Chamberlain; Michael V Volin; Mark Gonzalez; Richard M Pope; Arthur M Mandelin; Jay K Kolls; Shiva Shahrara
Journal:  Angiogenesis       Date:  2011-07-21       Impact factor: 9.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.